Evidence map›Paper›PMID 33476035›Full record

Observational studyJournal of endocrinological investigation2021

The silent variants of pituitary tumors: demographic, radiological and molecular characteristics.

M E Torregrosa-Quesada, A García-Martínez, A Sánchez-Barbie, S Silva-Ortega, R Cámara, C Fajardo, C Lamas, I Aranda, A Pico

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of endocrinological investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

M E Torregrosa-QuesadaDepartment of Biochemical Analysis, Alicante General University Hospital-Institute for Health and Biomedical Research (ISABIAL), 03010, Alicante, Spain.
A García-MartínezResearch Laboratory, Alicante General University Hospital-Institute for Health and Biomedical Research (ISABIAL). CIBER Rare Diseases, 03010, Alicante, Spain.
A Sánchez-BarbieCentro de Investigación Operacional (CIO), Miguel Hernández University, 03010, Alicante, Spain.
S Silva-OrtegaDepartment of Pathology, Alicante General University Hospital-Institute for Health and Biomedical Research (ISABIAL), 03010, Alicante, Spain.
R CámaraDepartment of Endocrinology and Nutrition, Polytechnic University Hospital La Fe, 46026, Valencia, Spain.
C FajardoDepartment of Endocrinology and Nutrition, Hospital La Ribera, Alzira, 46600, Valencia, Spain.
C LamasDepartment of Endocrinology and Nutrition, Albacete General University Hospital, 02006, Albacete, Spain.
I ArandaDepartment of Pathology, Alicante General University Hospital-Institute for Health and Biomedical Research (ISABIAL), 03010, Alicante, Spain.
A PicoDepartment of Endocrinology and Nutrition, Alicante General University Hospital. Institute for Health and Biomedical Research (ISABIAL). University Miguel Hernandez. CIBER Rare Diseases, 03010, Alicante, Spain. antonio.pico@umh.es.
Hospital General Universitario de Alicante Doctor Balmis · ESCentro de Investigación Biomédica en Red · ESHospital de La Ribera · ESHospital General Universitario de Albacete · ESHospital Universitari i Politècnic La Fe · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTumors of the anterior pituitary gland (PTs) are mostly benign tumors with a low prevalence, which has nevertheless increased with advances in brain radiology techniques. Nearly half of PTs are not associated with a clinical endocrine syndrome. These tumors have been indistinctly named non-functioning pituitary adenomas (NFPAs) or silent pituitary tumors (SPTs) and the mechanisms of silencing are not fully known.

aimTo study the frequency and characterize the silent variant of PTs in a large local series, and to assess their pituitary adenohypophyseal gene expression.

methodsThis observational, cross-sectional study was performed in a Pituitary Tumor Center of Excellence and involved 268 PTs. After identifying the different subtypes according to the immunohistochemical (IHC) expression of adenohypophyseal hormones, we studied their gene expression by RT-qPCR.

resultsWe found that silent tumors were larger and more invasive, but not more proliferative than their functional counterparts. The RT-qPCR complements the IHC typification of PTs, reducing the proportion of null-cell subtype. Finally, some silent PT subtype variants showed lower specific adenohypophyseal hormone gene expression than their functional counterparts, which may contribute to the absence of endocrine manifestations.

conclusionsThis paper highlights the importance of identifying the silent variant of the PTs subtypes. As expected, silent tumors were larger and more invasive than their functioning counterparts. However, there was no difference in the proliferation activity between them. Finally, the lower specific gene expression in the silent than in the functioning counterparts of some PTs subtypes gives insights into the silencing mechanisms of PTs.

Indexed as

AdenomaPituitary GlandPituitary Hormones, AnteriorPituitary NeoplasmsAsymptomatic DiseasesCross-Sectional StudiesFemaleGene Expression ProfilingHumansImmunohistochemistryMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingPrevalenceSpainPituitary Hormones, AnteriorAdenohypophyseal hormone gene expressionNon-functioning pituitary adenomas (NFPA)Pituitary tumorsSilent pituitary tumors (SPTs)

Identifiers

PMID33476035
OpenAlexW3121352759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.